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Background: Metabolic syndrome (MetS) is a clustering of five metabolic risk factors including abdominal
obesity, elevated blood pressure, hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C), and
impaired fasting glucose. Few studies have fully reported the strength of clustering of these risk factors in a
parent-offspring relationship. This analysis describes the associations between parents and their adult offspring
in regard to MetS. It also estimates the association between each risk factor in parents and the presence of
MetS in their offspring.
Methods: We analyzed data for 1193 offspring (565 sons, and 628 daughters) from the Framingham Offspring
Study who attended examinations 5, 6, and 7. Information about their parents was collected from examinations
13, 14 and 15 of the Framingham Original Cohort study. We used pedigree file to combine parental and
offspring’s data. Participants were classified as having the MetS according to the Adult Treatment Panel III
criteria. Analyses were conducted separately for mothers and fathers. Logistic regression was used to estimate
the associations.
Results: After adjusting for age, education, smoking, alcohol consumption and physical activity level of
offspring, no significant association was found between father’s and their offspring’s MetS. Mother’s MetS was
significantly and positively associated with their daughter’s MetS (adjusted odds ratio or adj OR: 1.63; 95%
confidence Interval, CI:1.02-2.61), but not with their sons’ MetS. When analyzed by individual components,
maternal impaired glucose (adj OR: 2.03; 95% CI: 1.02- 9.31), abdominal obesity (adj OR: 1.56; 95% CI: 0.98- 2.55) and
low HDL-C (adj OR: 2.12; 95% CI: 1.36-3.32) were associated daughter’s MetS. Maternal low HDL-C and raised total
cholesterol showed marginal association with son’s MetS. For fathers, only impaired glucose (adj OR: 4.91; 95%
CI: 2.07- 11.68) was associated with their daughter’s MetS.
Conclusions: Using the data from Framingham Heart Study, we demonstrate differential association of MetS and its
components between parents and offspring. Mother’s MetS was strongly related with daughter’s MetS, but the
association was inconsistent with son’s MetS. No association was found between father’s MetS and offspring’s Mets.
These results provide evidence that daughters with mother’s MetS are in higher risk than daughters or sons with
father’s MetS.
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Metabolic syndrome (MetS) is a clustering of five meta-
bolic risk factors including abdominal obesity, elevated
blood pressure, hypertriglyceridemia, low high-density
lipoprotein cholesterol (HDL-C), and impaired fasting
glucose (IFG). Adult Treatment Panel III (ATPIII) cri-
teria classifies individuals as having the MetS if they
have at least three of the above five risk factors [1,2].
Different studies have shown the association of MetS
and different components of MetS at different familial
level, including parent offspring, sibling-sibling, and
cousin-cousin relationship [3-7]. Some heritability stud-
ies have reported reasonable heritability of MetS and ac-
cording to various studies, heritability estimates for
MetS among Caucasian people range from approxi-
mately 14 to 27% [8-10]. Linkage analysis, genome-wide
association studies, and epigenetic studies have also
identified associated genes related to each of the compo-
nent of MetS [11,12]. But as MetS is the combined effect
of more than one risk factor, multiple genes are probably
involved in its development with varying degree of influ-
ence from multiple environmental and social factors
[13]. Although studies have shown the familial associ-
ation and considerable amount of heritability of MetS
and its components, few studies have directly and fully
reported the strength of clustering of these risk factors
in a parent-offspring relationship [5-7]. Most studies on
this issue have investigated the associations of MetS and
its components between adolescent or young children
and their parents [5,6]. The strength and the pattern of
the association of MetS between parents and offspring
could differ by offspring’s age since at a young age off-
spring live at their parents’ home and share the same en-
vironment. Therefore, it is important to include a wide
age range of the offspring to report the association fully.
Furthermore, it is also important to take into account
the important socio demographic and lifestyle character-
istics that contribute to this relationship. The multigen-
erational design of the Framingham Heart Study (FHS)
provides the unique opportunity to accurately investigate
this association. A better understanding of the magni-
tude and the pattern of these associations will improve
health professionals’ ability to reliably predict patient’s
cardiovascular risk from reported family history. This
study describes the associations between parents and
their adult offspring in regard to MetS. It also estimates
the association between each risk factor in parents and
the presence of MetS in their offspring.
Methods
Study population
Data for this study were drawn from the offspring and
original cohort of FHS. The original FHS cohort in-
cluded 5209 residents of Framingham, Mass, aged 28 to62 years who have been followed up with biennial exam-
inations from 1948 to present [14]. The offspring FHS
cohort included 5124 (3548 adult children of the original
cohort members and 1576 of their spouses) persons aged
5 to 70 years who have been followed up with examina-
tions every 4 to 8 years from 1971 to present [15]. Both
original and offspring FHS cohorts are predominantly
white [14,15]. At enrollment and during each follow up
participants of both cohorts completed a structured
interview with a detailed medical history and risk behav-
ior assessment, a physical examination, and laboratory
and other measurements. The FHS examination proto-
cols are reviewed by the institutional review board of the
Boston University Medical Center, Boston, Mass, and all
participants signed informed consent. FHS has presently
completed 31st Exam for the original cohort and the 8th
exam for the offspring cohort.
The current analysis included FHS offspring (age
21 years and above) who attended any of the offspring
FHS examinations 5, 6, or 7 (over time period, 1991–
2001). They were eligible for the present study if they
had at least one parent participated in any of the original
FHS exam 13, 14 or 15 (time period, 1972–1979). Using
the family pedigrees file, the data from parents and the
offspring examinations were combined that provided a
full range of parent-offspring cohort. After combining
the parent and offspring information using the pedigree
data, the final analysis included 1193 adult offspring
members (565 male offspring or sons, and 628 female
offspring or daughters) from the offspring study who
had information about either parent in the original co-
hort. Out of 1193 participants 897 offspring had infor-
mation about their mothers, 702 had information about
father and 406 had data about both parents.
Data collection
Information about socio-demographic (age, education
and income) and lifestyle characteristics (smoking status,
alcohol consumption and physical activity) for the off-
spring participants were obtained from the 5th examin-
ation (over time period, 1991–1997) of the offspring
cohort. Data on anthropometry, resting blood pressure,
blood glucose level, and lipid profiles for the offspring
were collected from the 5th, 6th and 7th examination
(over time period, 1991–2001). Their parents’ informa-
tion was obtained from 13th, 14th and 15th examina-
tions (time period, 1972–1979) of original cohort. We
combined the examinations for the offspring and their
parents to increase the sample size and to account for
the missing values. For both offspring and their parents,
measurements from the latest examination were used
for analysis. If there was any missing value in the latest
examination, measurements from the immediate previ-
ous examination was used.
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ATP III criteria were used to define MetS for offspring
and parents of FHS [1,2]. This classifies individuals as hav-
ing MetS if they have at least three of the following five
components: (1) abdominal obesity or large waist circum-
ference (>102 cm for men and > 88 cm for women); (2)
high triglyceride levels (fasting plasma triglyceride concen-
tration ≥ 1.7 mmol/l or on drug treatment); (3) low HDL-
C levels (<1.03 mmol/l for men and < 1.3 mmol/l in
women or on drug treatment); (4) elevated blood pressure
(≥130 mm Hg systolic or ≥ 85 mm Hg diastolic or on drug
treatment); or, (5) impaired fasting glucose or IFG
(≥6.1 mmol/l or on drug treatment).
For parents, data for waist circumference was not
available. We used body mass index or BMI (weight in
kg/height in meter square) as a substitute. BMI more
than or equal to 30 was used as a cut off to define obes-
ity. As the blood samples of parents were collected from
non-fasting state, IFG was considered present if the ran-
dom blood glucose level was ≥ 11.1 mmol/l or if they
used insulin or oral hypoglycemic agents [16]. For the
same reason, triglyceride values was also not used, in-
stead high blood cholesterol or total cholesterol level ≥
6.20 mmol/l and/ or use of cholesterol-lowering medica-
tions was used as a proxy [1].
Assessment of covariates
Information on the following covariates from the offspring
FHS were collected: age in years, sex, education (< high
school, high school, college graduate or higher), total fam-
ily income per year (< $20,000, $20,000- $44,000, $45,000
or higher), physical activity, smoking status and alcohol
consumption. Physical activity was assessed with a ques-
tionnaire, and was based on the average daily number of
hours of sleep and sedentary, slight, moderate, and heavy
activity of the participant. The composite score was calcu-
lated by summing the number of hours spent in each ac-
tivity intensity level and multiplying by a respective weight
factor derived from the estimated oxygen consumption
[17]. Participants were considered smokers if they had
smoked regularly in the previous year, otherwise they were
categorized as non-smokers. Alcohol use was dichoto-
mized on the basis of consumption of at least one drink
per week.
Analysis
Gender specific characteristics (socio-demographic sta-
tus, lifestyle characteristics, physical and laboratory mea-
surements) of participants were obtained and were
compared using the chi-square test or independent t
test. The primary outcome measure for this analysis was
presence of MetS among offspring evaluated as a dichot-
omous variable. And the main predictor was parental
MetS (either in both parents or in any parent). Analyseswere conducted separately for mothers and fathers. Lo-
gistic regression was used to examine the association be-
tween offspring and parental MetS stratified by gender.
Corresponding to each test, we report odds ratios and 95%
confidence intervals (CIs). First, we fitted unadjusted
models. We then fitted multivariable models adjusting for
confounding covariates, including offspring’s age in years,
education (< high school, high school, college graduate or
higher), smoking (2 level variable, smokers/non smokers),
physical activity scores, and alcohol use (2 level variable,
yes/no). Additional logistic regression was carried out to
examine the association of each component of parental
MetS (elevated blood pressure, obesity, low HDL-C, high
total cholesterol level and impaired fasting glucose) with
offspring’s MetS. Multivariable models were used to con-
trol for confounders using the above covariates.
Results
Our study participants included 565 male offspring or
sons and 628 female offspring or daughters. Table 1
shows the characteristics of the participants by gender.
The mean age was almost similar for male and female off-
spring members (the mean age was 52.57 ± 8.86 for male
and 53.33 ± 9.60 for female). Male offspring were however,
more educated and earned more than female offspring.
About 14% of female had college education compared to
26% of male participants. Approximately one quarter of
the male had a yearly income of $ 45,000 or above. While
only 2% female participants’ earning was in that range.
Male participants consumed more alcohol than female
(76.9% of male and 66.5% of female consumed alcohol, p
value < 0.001) and were more physically active than female
participant (mean physical activity score 36.19 ± 7.5 for
male and 33.81 ± 4.6 for female, p value < 0.001). Male off-
spring had higher waist circumference, serum triglyceride,
fasting blood glucose, resting blood pressure and lower
serum HDL-C than female offspring (p value <0.05 for all
except resting systolic blood pressure). Over all, about 43%
of the male offspring and 35.5% of the female offspring had
MetS (p value < 0.01). In terms of individual components,
male offspring had higher prevalence of elevated blood
pressure (65.3% versus 57.8%, p value < 0.01), elevated tri-
glyceride (54.3% versus 43.2%, p value < 0.001), IFG (32.0%
versus 16.2%, p value < 0.001) and low HDL-C (47.4%
versus 41.4%, p value < 0.05), than female offspring. Female
offspring however, had more abdominal obesity than male
members (66.4% versus 49.4%, p value < 0.001). Table 2
shows the distribution of parental clinical characteristics by
offspring’s gender. Mothers (mean age 69.47 years for male
and 70.49 for female offspring) were slightly older than fa-
thers (mean age 67.2 years for male and 68.36 for female
offspring). The prevalence of mother’s obesity and total
cholesterol level were higher than father’s prevalence of
obesity and cholesterol level for both male and female
Table 1 Characteristics of the 565 male and 628 female
offspring who had information about either parent’s
metabolic syndrome status in the Framingham Heart






Age 52.57 (8.86) 53.33 (9.60) 0.537
Education status, % <0.001
High school 34.3 38.4
College 39.5 47.5
More than college 26.2 14.1
Number of years of
school completed
14.35 (2.24) 13.91 (2.02) <0.01
Income Level, % <0.001
< $20,000, 11.1 63.2
$20,000- $44,000, 63.4 34.7




Alcohol consumption, %c 76.9% 66.5% <0.001
Physical activity Scored 36.19 (7.51) 33.81 (4.61) <0.001
Waist circumference (cm) 40.58 (4.43) 37.64 (5.78) <0.001
Serum triglyceride level (mmol/l) 1.54 (0.63) 1.42 (0.41) <0.05
Serum HDL-C level (mmol/l) 1.19 (0.33) 1.51 (0.40) <0.001
Resting systolic blood pressure 125.74 (17.41) 124.89 (20.52) 0.468
Resting diastolic blood pressure 75.81 (9.66) 72.58 (9.92) <0.001
Fasting blood glucose level 5.99 (1.58) 5.47 (1.14) <0.001
Abdominal obesity%e 49.4 66.4 <0.001
High Triglyceride%f 54.3 43.2 <0.001
Low HLD-C%g 47.4 41.4 <0.05
Elevated blood Pressure%h 65.3 57.8 <0.01
Impaired fasting glucose%i 32.0 16.2 <0.001
Metabolic syndrome%j 43.0 35.5 <0.01
Data presented as mean (SD) or percentage of subjects.
aIndependent t test or Chi-square test.
bSmokers if they had smoked regularly in the previous year.
cAlcohol use was dichotomized on the basis of consumption of at least one drink
per week.
dCalculated based on the average daily number of hours of sleep and
sedentary, slight, moderate, and heavy activity of the participant
ewaist circumference > 102 cm for men and > 88 cm for women
ffasting plasma triglyceride concentration ≥ 1.7 mmol/l or on drug treatment
gHDL cholesterol levels (<1.03 mmol/l for men and < 1.3 mmol/l in women or
on drug treatment.
hBlood pressure≥ 130 mm Hg systolic or≥ 85 mm Hg diastolic or on
drug treatment.
ifasting glucose ≥ 6.1 mmol/l or on drug treatment.
jMetabolic Syndrome defined as having at least three of the following five
components: (1) abdominal obesity or large waist circumference (>102 cm for
men and > 88 cm for women); (2) high triglyceride levels (fasting plasma
triglyceride concentration ≥ 1.7 mmol/l or on drug treatment); (3) low HDL
cholesterol levels (<1.03 mmol/l for men and < 1.3 mmol/l in women or on
drug treatment); (4) elevated blood pressure (≥130 mm Hg systolic or ≥
85 mm Hg diastolic or on drug treatment); or, (5) IFG or impaired fasting
glucose (≥6.1 mmol/l or on drug treatment).
Table 2 Parental characteristics of the 565 male and 628






Mother’s age in years 69.47 (8.01) 70.49 (7.86)) 0.07
Father’s age in years 67.2 (7.52) 68.36 (6.40) 0.34
Mother’s obesity %b 23.9 25.7 0.29
Father’s obesity % 20.5 22.7 0.28
Mother’s high cholesterol %c 63.0 61.5 0.35
Father’s high cholesterol % 33.7 37.2 0.12
Mother’s low HLD-C %d 36.8 36.6 0.50




Father’s elevated blood pressure % 87.5 88.5 0.31
Mother’s impaired blood glucose %f 6.6 8.9 0.11
Father’s impaired blood glucose % 10.1 8.7 0.31
Mother’s metabolic syndrome %g 25.5 28.9 0.26




Data presented as mean (SD) or percentage of subjects.
aIndependent t test or Chi-square test.
bbody mass index ≥ 30.
ctotal cholesterol level ≥ 6.20 mmol/l and/ or use of
cholesterol-lowering medications.
dHDL cholesterol levels (<1.03 mmol/l for men and < 1.3 mmol/l in women or
on drug treatment.
eBlood pressure ≥ 130 mm Hg systolic or ≥ 85 mm Hg diastolic or on
drug treatment.
frandom blood glucose level ≥ 11.1 mmol/l or if they used insulin or oral
hypoglycemic agents.
gMetabolic Syndrome defined as having at least three of the following five
components: (1) body mass index ≥ 30; (2) total cholesterol level ≥ 6.20 mmol/l
and/or use of cholesterol-lowering medications; (3) low HDL cholesterol levels
(<1.03 mmol/l for men and < 1.3 mmol/l in women or on drug treatment);
(4) elevated blood pressure (≥130 mm Hg systolic or ≥ 85 mm Hg diastolic or
on drug treatment); or, (5) random blood glucose level ≥ 11.1 mmol/l or if they
used insulin or oral hypoglycemic agents.
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vated blood pressure, impaired blood glucose and low
HDL-C were higher than mother’s prevalence of ele-
vated blood pressure, impaired blood glucose and low
HDL-C for male and female offspring. However, overall,
the clustering of the risk factors or the prevalence of
maternal MetS was higher than paternal MetS for both,
male (prevalence was 25.5% for maternal and 14.6% for
paternal MetS) and female (prevalence was 28.9% for
maternal and 17.5% for paternal MetS) offspring. About
4.9% of male and about 7.7% of female offspring’s both
parents had MetS.
Table 3 presents the characteristics of participants by
MetS status. Men had higher MetS prevalence than
women. Participants who had MetS were older (mean
age 55.06 versus 51.63, p value <0.001), were less edu-
cated (14.4% with MetS went to more than college
Table 3 Characteristics of the participant by metabolic













Education status % <0.01
High school 41.8 33.2
College 43.8 43.6
More than college 14.4 23.2
Number of years of
school completed
13.80 (2.06) 14.31 (2.15) <0.001
Income level % 0.39
< $20,000, 38.5 36.8
$20,000- $44,000 49.8 48.2
$45,000 or higher 11.7 15.0
Smoked cigarettes
regularly last year %b
24.3 19.4 <0.05
Alcohol consumption %c 64.2 76.1 <0.001
Physical activity scored 34.67 (6.53) 35.09 (6.04) 0.27
Data are mean (SD) or percentage of subjects.
aIndependent t test or Chi-square test.
bSmokers if they had smoked regularly in the previous year.
cAlcohol use was dichotomized on the basis of consumption of at least one
drink per week.
dCalculated based on the average daily number of hours of sleep and
sedentary, slight, moderate, and heavy activity of the participant.
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to be smoker (24.3% with MetS smoked versus 19.4%
without MetS, p value < 0.05), and less likely to consume
alcohol (64.2% with MetS consumed alcohol versus
76.1% without MetS, p value < 0.001)
The association between parental and offspring’s
MetS are presented in Table 4. After adjusting for age,
education, smoking, alcohol consumption and physical
activity level of offspring, no significant association was
found between father’s and their offspring’s MetS.
Mother’s MetS was significantly and positively associ-
ated with their female offspring or daughters’ MetS.
Daughters with mother’s MetS had 63% (adjusted odds
ratio or adj OR: 1.63; 95% confidence Interval, CI:1.02-
2.61) increased odds of developing MetS compared to
daughters whose mothers didn’t have met syndrome. No
significant relationship was noted between mother’s MetS
and their male offspring or their son’s MetS. Offspring
were however at increased risk if both parents had
MetS. Daughters (adj OR: 3.64; 95% CI:1.11-13.07) and
sons (adj OR: 4.21; 95% CI: 0.69-25.9) both had about 4folds of increased odds of having MetS if both parents
had MetS compared to offspring whose neither or single
parent had MetS.
We estimated the association between each individual
risk factor of parents and the presence of MetS among
their offspring in Table 5. When analyzed by individual
components, the adjusted analysis showed a similar pat-
tern of association between mothers and daughters that
we observed previously with the combination or cluster-
ing of risk factors. Individual risk factors of mothers were
also significantly associated with presence of MetS in their
daughters as clustering of the risk factors was. Mother’s
impaired blood glucose (adj OR: 2.03; 95% CI: 1.02- 9.31),
obesity (adj OR: 1.58; 95% CI: 0.98- 2.56) and low HDL-C
(adj OR: 2.01; 95% CI: 1.36-3.32) were independently asso-
ciated daughter’s MetS. None of these were significant for
their son’s MetS. But maternal raised total cholesterol was
marginally associated with their son’s MetS (adj OR: 1.60;
95% CI: 0.99-2.58). For fathers, only impaired blood glu-
cose (adj OR: 4.91; 95% CI: 1.77- 11.67) was significantly
associated with their daughter’s MetS. None of individual
risk factors in fathers was significantly associated with
their son’s MetS
Discussion
Using the parents and offspring data from FHS, we
found differential association of MetS and its compo-
nents between parents and offspring. In our study, ma-
ternal MetS was significantly associated with daughter’s
MetS, but not with son’s MetS. Individual maternal risk
factors like impaired blood glucose, obesity, and low
HDL-C were also independently associated with daugh-
ter’s MetS. Maternal low HDL-C and raised total choles-
terol showed marginal association with son’s MetS. The
relationship between father-offspring in regard to the
presence of MetS was however, relatively weaker and
didn’t reach conventional level of significance. Only fa-
ther’s impaired blood glucose had significant association
with their daughter’s MetS.
It is widely accepted that cardiovascular disease and
risk factors are heritable through generations from par-
ents to offspring and intergenerational associations of in-
dividual cardiovascular risk factors have been reported
in a number of studies [18-29]. However, to our know-
ledge, very few studies have measured the association of
MetS or clustering of risk factors between parents and
offspring. One study conducted in Korean population
found a strong parent–offspring association for MetS be-
tween adolescents and their parents [6]. However, they
didn’t report on differential transmission from mothers
or fathers. The only work that we found reporting differ-
ential association is from Fels Longitudinal Study data
[7]. Unlike the current study, the FeLs study showed a
significant association between sons, and both mothers
Table 4 Association between parental and offspring’s metabolic syndrome in Framingham Heart Study (N = 1193)
Metabolic syndrome Metabolic syndrome
Female offspring or daughters (N = 628) Male offspring or sons (N = 565)
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Mother Unadjusted 1.96 (1.31-2.93) 0.001 1.26 (0.81-1.94) 0.30
Adjusteda 1.63 (1.02-2.61) 0.04 1.17 (0.70-1.94) 0.54
Father Unadjusted 1.24 (0.67-2.32) 0.50 0.97 (0.50-1.89) 0.86
Adjusteda 1.21 (0.59-3.12) 0.19 1.12 (0.53-2.50) 0.72
Both parents Unadjusted 3.96 (1.23-9.77) 0.01 4.88 (1.20-20.71) 0.02
Adjusteda 3.64 (1.11-13.07) 0.015 4.21 (0.69-25.9) 0.11
Metabolic Syndrome defined as having at least three of the following five components: (1) abdominal obesity or large waist circumference (>102 cm for men
and > 88 cm for women); (2) high triglyceride levels (fasting plasma triglyceride concentration ≥ 1.7 mmol/l or on drug treatment); (3) low HDL cholesterol levels
(<1.03 mmol/l for men and < 1.3 mmol/l in women or on drug treatment); (4) elevated blood pressure (≥130 mm Hg systolic or ≥ 85 mm Hg diastolic or on drug
treatment); or, (5) IFG or impaired fasting glucose (≥6.1 mmol/l or on drug treatment).
aThe multivariate models are adjusted for age, education, smoking, alcohol consumption, physical activity score.
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and mothers. One of the reasons behind this difference
in the results could be the inclusion of young aged off-
spring in their analysis. As the onset of cardiovascular
disease and cardiovascular risk factors is usually later in
female than in male, probably inclusion of young aged
offspring (18–32 years) masked the relationship between
daughter and mothers in the Fels Study when MetS or
clustering of risk factors was considered due to low
prevalence of MetS among young daughters [30]. But in
the same study, maternal presence of MetS was signifi-
cantly and positively related with individual risk factors
like blood pressure and triglycerides in female offspring
indicating that with progress of age, mother-daughter as-
sociation in regard to clustering could become signifi-
cant. Also this study didn’t adjust for important lifestyle
or socio-demographic characteristics such as, alcohol
and smoking behavior, level of physical activity, and edu-
cation. The stronger parent- son association that they
found might have become weaker if those factors were
accounted for. Among the individual components of
MetS, to date, researchers have mostly focused on measur-
ing intergenerational transmission of obesity and insulin
resistance or diabetes. A number of longitudinal and ob-
servational studies have shown stronger maternal–off-
spring transmission of type 2 diabetes [18-20]. But the
evidence on differential transmission of obesity or BMI is
mixed. Some studies have reported a stronger maternal
than paternal parent offspring association of BMI and
obesity [21-24], whereas others have showed similar asso-
ciations [25-28].
The parental transmission of different risk factors or
clustering of risk factors can be attributed to both gen-
etic and environmental factors. We adjusted for import-
ant lifestyle and socio-demographic characteristics such
as, smoking and alcohol consumption, level of physical
activity, and education to estimate the accurate parent-offspring association of MetS and its components. These
adjustments attenuated the risk estimates. But a signifi-
cant association that remained even after the adjust-
ment, mainly with maternal MetS and with maternal
risk factors, suggests that this specific maternal effect
could be partly attributed to a direct effect of maternal
uterine environment on the development of fetus. Dur-
ing the past few decades, particular attention has been
given to maternal health and exposure during pregnancy
influencing the future health of the offspring. It is now
believed by many scientists that intrauterine conditions
can alter the structure and function of organs and
physiological systems in the fetus, and can be a cause for
subsequent adult disease like adulthood hypertension,
insulin resistance and an abnormal lipid profile [31-36].
This alteration of physiological systems can originate
through adaptive processes, which the fetus makes when
the environment in intrauterine life is unfavorable. This
unfavorable condition can be caused by different envir-
onmental stimuli like, maternal under nutrition, mater-
nal stress, maternal exposure to toxins, maternal genes
affecting placental function, etc. [37]. Differential associ-
ation of risk factors may also possibly be influenced by
differential gene expression between men and women.
Scientists have identified several chromosomal regions that
are sex-specifically involved in influencing different traits
of metabolic syndrome [38]. An increasing body of evi-
dence also supports the role of environmentally-induced
epigenetic changes in disease susceptibility. Experimental
studies in mice suggest a role for maternal diet in inducing
epigenetic changes in the offspring [39,40]. This would
make the mother’s influence on offspring greater than the
father’s influence, as our finding indicates.
Besides being part of this biological interaction, maternal
dietary habit itself can also have an independent role to
play. A research done on nationally representative US
sample showed that resemblance in diet between mother–
Table 5 Association between cardiovascular risk factor in parents and the presence of metabolic syndrome in their
offspring in Framingham Heart Study (N = 1193)
Risk factors Metabolic syndrome
Female offspring N = 628 Male offspring N = 565
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Mother
Elevated BPb Unadjusted 2.04 (1.16-3.58) 0.01 1.77 (1.01-3.11) 0.04
Adjusteda 1.42 (0.71-2.8) 0.32 1.28 (0.67-2.45) 0.46
Impaired BGc Unadjusted 3.15 (1.61-6.17) 0.001 0.801 (0.37-1.7) 0.57
Adjusteda 2.03 (1.02- 9.31) 0.04 0.40 (0.18-1.22) 0.12
Obesityd Unadjusted 1.81 (1.19-2.74) 0.005 1.596 (1.02-2.5) 0.04
Adjusteda 1.58 (0.98-2.56) 0.06 1.41 (0.83-2.39) 0.20
Raised total-Ce Unadjusted 1.15 (0.79-1.67) 0.475 1.49 (1.00-2.22) 0.05
Adjusteda 1.12 (0.72-1.80) 0.38 1.60 (0.99-2.58) 0.05
Low HDL-Cf Unadjusted 2.05 (1.40-3.00) 0.000 1.39 (0.89-1.95) 0.15
Adjusteda 2.01 (1.36-3.32) 0.001 1.47 (0.93-2.36) 0.09
Father
Elevated BP Unadjusted 1.21 (0.54-2.74) 0.64 1.37 (0.64-2.90) 0.41
Adjusteda 0.88 (0.32-1.84) 0.48 1.62 (0.65-4.00) 0.24
Impaired BG Unadjusted 3.35 (1.60-7.02) 0.001 1.36 (0.60-2.66) 0.53
Adjusteda 4.91 (1.77-11.67) 0.001 1.38 (0.56-3.36) 0.48
Obesity Unadjusted 1.29 (0.73-2.28) 0.39 1.08 (0.61-1.92) 0.79
Adjusteda 1.81 (0.87-3.6) 0.12 1.31 ( 0.67-2.67) 0.4
Raised total-C Unadjusted 1.33 (0.81-2..21) 0.26 0.93 (0.56-1.54) 0.78
Adjusteda 1.42 (0.79-2.68) 0.22 0.83 (0.45-1.52) 0.54
Low HDL-C Unadjusted 1.53 (0.84-2.77) 0.16 1.43 (0.81-2.42) 0.22
Adjusteda 1.48 (0.73-2.98) 0.27 1.45 (0.77-2.74) 0.24
BP: Blood pressure, BG: Blood glucose, Total-C: Total Cholesterol, HDL-C: HDL cholesterol.
aThe multivariate models are adjusted for age, education, smoking, alcohol consumption, physical activity score.
bBlood pressure ≥ 130 mm Hg systolic or ≥ 85 mm Hg diastolic or on drug treatment.
crandom blood glucose level ≥ 11.1 mmol/l or if they used insulin or oral hypoglycemic agents.
dbody mass index ≥ 30.
etotal cholesterol level ≥ 6.20 mmol/l and/or use of cholesterol-lowering medications.
fHDL cholesterol levels (<1.03 mmol/l for men and < 1.3 mmol/l in women or on drug treatment.
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father–child counterparts [41]. Thus, if the dietary habit of
mothers with MetS is unhealthy, the chance of inheriting
that poor dietary habit of mother is increased among
daughters compared to their sons. It is also possible that
maternal feeding strategies act as a contributor to these ef-
fects. In one study obese mothers reported significantly less
control over their children's food intake [42]. There can be
sex specific adoption of other behaviors of parents like,
physical activity, smoking etc. and this can also cause differ-
ential associations of risk factors that we found [43,44].
Our results should be interpreted within the context of
few limitations and strength. We acknowledge the consid-
erable disagreement over the definition and diagnosticcriteria related to MetS. Of the various available defini-
tions, we used the ATPIII criteria as this is the most
widely used definition in the US [1,45]. It can be argued
that some other available definition of MetS could be
equally valid and produce somewhat different result. But it
is largely believed that metabolic syndrome, however de-
fined, remains pretty similar in prevalence and in risk pre-
diction for Caucasian population [46,47]. Thus, we are
confident that our estimations are pretty accurate. It
should be mentioned that we used some proxy measures
for parents to define MetS. BMI was used instead of WC,
and as parent cohort had non fasting blood, we used total
cholesterol level instead of triglyceride and fasting sugar
level of ≥11.1 mmol/l for defining insulin resistance.
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these surrogate measures, we might have introduced a
non-differential exposure misclassification bias in our
study. This possibly has increased the similarity between
the exposed and non-exposed groups, and has underesti-
mated the associations in our study [49]. However, there is
a very slim possibility that the underestimation was sub-
stantial, as we found the similar pattern of parent–off-
spring association when we estimated the risk of
offspring’s MetS by individual parental risk factors. The
Framingham cohorts are almost exclusively white and one
of the limitations of study includes its inability to generalize
the findings to other ethnic groups. The generalizability of
the study might be little limited, but this large community
based study allowed us avoid systematic errors introduced
by self-reported health status of parents. Most of the stud-
ies reporting parent-offspring cardiovascular risk factors
association depend on self-reported parental health infor-
mation and are prone to this error. Because we used ob-
jectively measured parental anthropometric and
laboratory data, the current analysis remained free from
this bias. Another strength of the study was that we in-
cluded adult offspring for our analysis when they didn’t
share household with their parents. This improved the
precision of our analysis as the calculated estimates were
independent of shared familial environmental factors.
Our demonstration of associations between maternal
and offspring’s MetS suggests that interventions to re-
duce the prevalence of MetS aimed at family level and
earlier in life are likely to be beneficial. Interventions
should be targeting on weakening the link between ma-
ternal MetS and offspring’s MetS and its components.
This can be achieved by warning parents with MetS,
mothers in particular, about their offspring’s increased
risk of getting MetS and by encouraging them to pro-
mote healthy lifestyle at family level for themselves and
for their children. Our findings support the proposition
that maternal effect is transmitted through intrauterine
mechanisms. From public health point of view, this sug-
gests that adulthood diseases could be prevented by im-
proving maternal health and fetal development. This
inspires future research to explore the relationships be-
tween different conditions of prenatal, natal and post
natal life. Identifying the common mechanisms and
pathways involved in these relationships will help to de-
termine the issues to optimize maternal health, birth
outcome, and lifelong health of the offspring. Our find-
ings also indicate that family history about multiple risk
factors in parent, especially in mothers can add value in
offering prognosis and risk assessment. If there is a posi-
tive family history of MetS, individual risk factors such as
hypertension, obesity, or hypercholesterolaemia should be
treated more aggressively so that clustering of the risk fac-
tors are prevented or delayed.Conclusion
We found differential association of MetS and its compo-
nents between parents and offspring. Mother’s MetS was
strongly related with daughter’s MetS, but the association
was inconsistent with son’s MetS. However, no association
was found between father’s MetS and offspring’s Mets. We
recommend further studies to examine the effects of early
life environments and epigenetics on adults MetS. We also
think policies and health educational programs should be
directed towards families, in particular towards women for
future CVD risk reduction.
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